搜索临床试验以:INV-202
总计17209个结果
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR); Abbott Medical Devices完全的
-
Heart and Diabetes Center North-Rhine WestfaliaItamar-Medical, Israel完全的
-
Synchroneuron Inc.撤销创伤后应激障碍 | 应激障碍,创伤后 | 创伤后应激障碍 | 创伤后应激障碍,与战斗有关
-
Syneos HealthAsieris Pharmaceuticals (AUS) Pty Ltd.尚未招聘
-
University of CalgaryAlberta Innovates Health Solutions; Wave View Imaging招聘中
-
Shanghai Bensen Pharmaceutical Co., Ltd.尚未招聘急性髓性白血病、骨髓增生异常综合征
-
Inovio PharmaceuticalsGeneOne Life Science, Inc.; Defense Advanced Research Projects Agency完全的
-
CuraSen Therapeutics, Inc.完全的
-
Stephen Bagley, MD, MSCEUniversity of Pennsylvania; Abramson Cancer Center at Penn Medicine主动,不招人
-
Centre Hospitalier Universitaire Saint Pierre终止
-
BrainScope Company, Inc.完全的
-
Orion Corporation, Orion Pharma完全的
-
Pharma PlantNovagenix Bioanalytical Drug R&D Center未知
-
Calypso Biotech BV完全的
-
Minoryx Therapeutics, S.L.主动,不招人
-
Atriva Therapeutics GmbH终止
-
Scilex Pharmaceuticals, Inc.Worldwide Clinical Trials; Semnur Pharmaceuticals, Inc.完全的
-
London North West Healthcare NHS Trust主动,不招人大肠癌 | 直肠癌 | 肌肉减少症 | 晚期癌症 | 结肠癌 | 结直肠癌 | 肌肉减少性肥胖 | 复发性直肠癌英国
-
Orion Biotechnology Polska Sp. z o.o.Scope International AG完全的
-
University of FloridaTaiho Oncology, Inc.终止
-
Prof. Dr. Dieter WillboldMedical University of Vienna; Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany; NeuroScios... 和其他合作者完全的